Computational and experimental tool for cancer protein

Information

  • Research Project
  • 6712773
  • ApplicationId
    6712773
  • Core Project Number
    R43CA099053
  • Full Project Number
    5R43CA099053-02
  • Serial Number
    99053
  • FOA Number
    PAR-01-107
  • Sub Project Id
  • Project Start Date
    3/7/2003 - 22 years ago
  • Project End Date
    2/28/2005 - 20 years ago
  • Program Officer Name
    HEATH, ANNE K
  • Budget Start Date
    3/1/2004 - 21 years ago
  • Budget End Date
    2/28/2005 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    2
  • Suffix
  • Award Notice Date
    1/20/2004 - 21 years ago
Organizations

Computational and experimental tool for cancer protein

DESCRIPTION (provided by applicant): In the predominant sequence-to-function paradigm, 3-D structure is an obligatory prerequisite for protein function. Even though over 100 counterexamples can be found in literature, generalization of the functions associated with nonfolded (disordered) protein has been mostly ignored. Application of our proprietary bioinformatics software, PONDR, to a comprehensive set of oncogenes revealed that these proteins are likely to contain significantly more disorder than other protein types. This result, combined with indications that disorder is crucial to many protein functions, demand that disorder be considered explicitly in the study of human disease. Thus, cancer-specific data mining will produce "Cancer DisProt," containing correlations of disorder/order with protein function, is proposed. Disorder/order predictions and existing structural knowledge will be correlated with functions of cancer-associated proteins and augmented with local interaction networks to provide an interactive resource tool for cancer-related research. A companion methods manual will facilitate the integration of order/disorder knowledge into novel experiments. Cancer DisProt will be a useful bioinformatics tool for functional annotation of entire genomes. When augmented with methods for studying counter-example proteins, it will provide the basis for design of novel approaches to development of cancer treatments or drug discovery.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    131575
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:131575\
  • Funding Mechanism
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MOLECULAR KINETICS, INC.
  • Organization Department
  • Organization DUNS
    183789163
  • Organization City
    INDIANAPOLIS
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    46268
  • Organization District
    UNITED STATES